Since we could demonstrate a significant influence of HFD-induced atherosclerosis and myocardial infarction on circulating CRAMP levels in the experimental mouse models, we investigated CAMP serum levels in CAD patients in a translational approach. The gene discussed is CAMP; the disease is myocardial infarction.